CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.
CHPA submitted comments this week to the Food and Drug Administration regarding the proposed development of an authorized list of dietary ingredients marketed prior to the Dietary Supplement Health and Education Act.
Echoing earlier comments submitted to the agency, CHPA and its member companies marketing dietary supplement products support the presumption of safety for dietary ingredients outlined in the 1994 passage of DSHEA.
The industry favors and supports the development of reasonable guidance. However, the agency’s attempt to redefine the NDI notification process contradicts the letter and spirit of DSHEA. The Draft Guidance would undo nearly two decades of agency practice and policy.
Advertising and marketing of dietary supplements are regulated by the FDA, the FTC, and other governmental organizations. Products must be deemed safe prior to marketing and advertisement claims must be substantiated.